Kevin T. Conroy, Abbott Laboratories: Form 4 of Sept. 30, 2026
As it stands
| Day | Trade | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Sept. 30, 2026 | Granted or awarded by the company | Stock Equivalent Units | 318 | $98.83 | $31,427.94 | 551 |
The filing at EDGAR (accession 0001104659-26-113286)
The record
Source: the U.S. Securities and Exchange Commission’s EDGAR, read .